|
|
Legal status
Patent in force
| (51) | INT.CL. | C07K 16/00 | (2006.01) |
| A61K 38/17 | (2006.01) | ||
| A61K 45/06 | (2006.01) | ||
| C07K 16/28 | (2006.01) | ||
| C07K 16/40 | (2006.01) | ||
| C07K 14/47 | (2006.01) | ||
| A61K 39/00 | (2006.01) |
| (11) | Number of the document | 3268391 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16719896.9 |
| Date of filing the European patent application | 2016-03-08 | |
| (97) | Date of publication of the European application | 2018-01-17 |
| (45) | Date of publication and mention of the grant of the patent | 2021-08-11 |
| (46) | Date of publication of the claims translation | 2021-09-10 |
| (86) | Number | PCT/IB2016/000398 |
| Date | 2016-03-08 |
| (87) | Number | WO 2016/142782 |
| Date | 2016-09-15 |
| (30) | Number | Date | Country code |
| 201562130076 P | 2015-03-09 | US |
| (72) |
ONGENAE, Nicolas, G.h. , BE
DREIER, Torsten , BE
ULRICHTS, Peter , BE
DE HAARD, Johannes , NL
BLANCHETOT, Christophe , BE
|
| (73) |
ARGENX BV,
Industriepark-Zwijnaarde 7, 9052 Zwijnaarde (Ghent),
BE
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Fc turinčių agentų kiekių serume sumažinimo būdai, panaudojant FcRn antagonistus |
| METHODS OF REDUCING SERUM LEVELS OF FC-CONTAINING AGENTS USING FCRN ANTAGONSITS |
| Payment date | Validity (years) | Amount | |
| 2026-02-24 | 11 | 289.00 EUR |
| 2027-03-08 |